Single-use Bioprocessing Material Market Size, Share, Growth, and Industry Analysis, By Type (Plastic, Silicone, Other), By Application (Biopharmaceutical Manufacturers, Life Science R&D and Academic Research Institutes, Contract Research Organization & Manufacturers, Others), Regional Insights and Forecast to 2034

Single-use Bioprocessing Material Market Overview

The Single-use Bioprocessing Material - Market size was valued at USD 4663.59 million in 2025 and is expected to reach USD 11907.31 million by 2034, growing at a CAGR of 10.6% from 2025 to 2034.

The Single-use Bioprocessing Material Market has expanded significantly with over 75% of biopharmaceutical manufacturers integrating single-use systems in upstream or downstream processes as of 2024. More than 12,000 bioprocessing facilities globally utilize disposable bags, filters, and tubing assemblies, with over 65% of new biologics manufacturing lines designed as single-use facilities. Approximately 40% of global monoclonal antibody production capacity under 2,000 liters relies on single-use bioprocessing materials. Over 55% of vaccine production facilities implemented single-use assemblies post-2020. The Single-use Bioprocessing Material Market Report indicates that more than 70% of clinical-scale biologics manufacturing now depends on disposable materials for contamination control and faster turnaround cycles.

In the United States, over 60% of biologics manufacturing facilities use single-use bioprocessing materials for at least one production stage. The U.S. accounts for approximately 35% of global installed single-use bioreactor capacity under 2,000 liters. More than 500 FDA-registered biologics facilities operate with single-use components integrated into purification and filtration lines. Around 80% of U.S.-based CDMOs use disposable tubing and bag assemblies in pilot-scale operations. The Single-use Bioprocessing Material Market Analysis shows that over 45% of newly approved biologics between 2021 and 2024 were produced in facilities incorporating single-use technologies.

• 

  Download Free sample to learn more about this report.

Key Findings

• Key Market Driver:Over 75% adoption in clinical biologics manufacturing, 68% contamination reduction rates, 50% reduction in cleaning validation time, 60% faster batch changeover, 72% implementation in vaccine production, and 65% preference among CDMOs for flexible manufacturing.
• Major Market Restraint:35% supply chain disruption impact, 28% raw material dependency risk, 32% extractables and leachables concerns, 25% waste disposal limitations, 30% high import reliance for polymer resins, and 22% regulatory compliance delays.
• Emerging Trends:55% growth in single-use sensors integration, 48% expansion in hybrid stainless-steel systems, 63% increase in modular facility adoption, 52% automation compatibility rate, 58% uptake in mRNA production, and 47% digital monitoring implementation.
• Regional Leadership:North America holds 38% market share, Europe accounts for 30%, Asia-Pacific represents 24%, Middle East & Africa contribute 5%, and Latin America captures 3% of total global deployment.
• Competitive Landscape:Top 5 manufacturers control 62% market share, top 2 companies hold 38%, 45% of suppliers focus on filtration products, 33% specialize in bag assemblies, and 27% invest in automation-compatible disposables.
• Market Segmentation:Plastic materials represent 64% share, silicone accounts for 21%, other materials contribute 15%; biopharmaceutical manufacturers hold 58% demand share, CROs 22%, research institutes 14%, others 6%.
• Recent Development:48% increase in capacity expansion projects in 2023–2024, 35% rise in automation-ready product launches, 40% growth in sterile connector innovation, 29% sustainability-focused product upgrades, and 33% expansion in Asia-Pacific facilities.

Single-use Bioprocessing Material Market Latest Trends

The Single-use Bioprocessing Material Market Trends indicate that over 63% of newly constructed biologics plants under 2,000-liter capacity are fully disposable-based facilities. Approximately 58% of mRNA and cell therapy manufacturing lines installed after 2021 rely on single-use bags and tubing assemblies. Around 46% of manufacturers report a 30% reduction in cross-contamination incidents after shifting to disposable flow paths. The Single-use Bioprocessing Material Market Research Report highlights that over 52% of companies have integrated real-time monitoring sensors into disposable bioreactor systems.

Hybrid systems combining stainless steel and single-use components account for nearly 42% of large-scale facilities above 2,000 liters. More than 55% of filtration steps in downstream processing now use disposable membrane filters. Sustainability initiatives have increased polymer recycling initiatives by 18% between 2022 and 2024. The Single-use Bioprocessing Material Market Outlook shows that over 70% of CDMOs prefer single-use platforms for multi-product facilities handling more than 5 biologics annually.

Single-use Bioprocessing Material Market Dynamics

DRIVER

Rising demand for biologics and advanced therapies

Over 50% of new drug approvals between 2021 and 2024 were biologics, increasing dependency on flexible manufacturing systems. More than 65% of monoclonal antibody production facilities operate under 2,000-liter scale, favoring single-use systems. Approximately 72% of vaccine facilities implemented disposable bioprocessing assemblies after 2020. Around 60% of cell and gene therapy production sites rely exclusively on single-use platforms. The Single-use Bioprocessing Material Market Growth is strongly driven by 45% shorter facility construction timelines and 35% lower validation cycles compared to traditional systems.

RESTRAINT

Waste management and material disposal concerns

Single-use systems generate approximately 3–5 kg of plastic waste per 1,000-liter batch. Nearly 40% of manufacturers report challenges in recycling multi-layer polymer films. Around 28% of regulatory inspections focus on extractables and leachables data validation. Approximately 30% of raw materials are sourced from limited global polymer suppliers. The Single-use Bioprocessing Material Industry Analysis shows that 22% of manufacturers face import-related delays exceeding 4 weeks.

OPPORTUNITY

Expansion in emerging markets biomanufacturing

Asia-Pacific has increased biologics manufacturing facilities by 35% between 2021 and 2024. Nearly 48% of new facilities in India, China, and South Korea adopt single-use systems. Government-supported biotech parks in over 12 countries have integrated disposable production lines. Approximately 55% of new CDMO facilities in Southeast Asia use modular single-use setups. The Single-use Bioprocessing Material Market Opportunities are strengthened by 60% faster deployment of prefabricated facilities.

CHALLENGE

Supply chain volatility and standardization gaps

During 2020–2022, 38% of manufacturers experienced delays exceeding 6 weeks in obtaining disposable bags and filters. Over 25% reported inconsistencies in tubing compatibility across suppliers. Approximately 31% of companies require dual-supplier qualification strategies. Around 27% face batch-to-batch variability testing requirements. The Single-use Bioprocessing Material Market Forecast identifies standardization challenges across more than 20 regulatory jurisdictions.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

The Single-use Bioprocessing Material Market Size is segmented by type and application, with plastics accounting for 64% share, silicone 21%, and other materials 15%. By application, biopharmaceutical manufacturers contribute 58% demand, CROs 22%, research institutes 14%, and others 6%. Over 70% of disposable bags are plastic-based, while 80% of sterile connectors use polymer composites.

By Type

Plastic:Plastic materials account for approximately 64% of the Single-use Bioprocessing Material Market Share. Over 75% of disposable bioreactor bags are multi-layer polyethylene-based. Nearly 68% of tubing assemblies use thermoplastic elastomers. Around 50% of filtration membranes incorporate polypropylene. Plastic-based systems reduce cleaning cycles by 60% and lower contamination risks by 45%.

Silicone:Silicone materials represent 21% market share and are used in 55% of high-flexibility tubing applications. Approximately 48% of peristaltic pump tubing utilizes platinum-cured silicone. Silicone withstands temperatures up to 200°C in sterilization processes. Around 35% of advanced cell therapy systems require silicone connectors for flexibility and chemical resistance.

Other:Other materials contribute 15% share, including fluoropolymers and polycarbonate components. Nearly 30% of sterile connectors use specialized composite polymers. Around 25% of high-pressure filtration capsules rely on polycarbonate housings. These materials provide 40% higher chemical resistance compared to standard plastics.

By Application

Biopharmaceutical Manufacturers:Biopharmaceutical manufacturers account for 58% demand. Over 70% of monoclonal antibody production lines integrate disposable bags. Approximately 65% of vaccine production lines utilize single-use filters. Around 50% of upstream fermentation steps rely on disposable bioreactors under 2,000 liters.

Life Science R&D and Academic Research Institutes:Research institutes represent 14% demand. Nearly 60% of university bioprocess labs use single-use systems. Around 45% of pilot-scale experiments adopt disposable filtration units. Over 30% of translational research centers prefer modular single-use platforms.

Contract Research Organization & Manufacturers:CROs and CDMOs account for 22% demand. Approximately 80% of CDMOs utilize disposable assemblies for multi-product manufacturing. Around 55% of clinical trial batches use single-use upstream systems. Nearly 48% report 25% faster changeover times.

Others:Other applications contribute 6%, including diagnostic manufacturers and veterinary biologics producers. Nearly 35% of diagnostic reagent facilities use disposable mixing systems. Around 20% of veterinary vaccine facilities utilize single-use purification assemblies.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

• North America holds 38% share with over 500 operational biologics facilities.
• Europe accounts for 30% share with more than 350 GMP-certified biologics sites.
• Asia-Pacific represents 24% share with 200+ expanding biomanufacturing plants.
• Middle East & Africa hold 5% share with 40+ emerging biotech hubs.

North America

North America commands 38% of the Single-use Bioprocessing Material Market Share. The U.S. operates over 500 biologics manufacturing sites, with 60% integrating disposable systems. Canada contributes 8% regional share with 40+ GMP biologics facilities. Around 75% of CDMOs in the region deploy single-use upstream systems. More than 50% of clinical-scale production relies on disposable filtration units.

Europe

Europe accounts for 30% share with Germany, France, and the UK representing over 65% of regional demand. Approximately 55% of European biologics facilities under 2,000 liters utilize disposable bioreactors. Over 40% of vaccine production facilities transitioned to hybrid systems between 2021 and 2024. Nearly 48% of EU-funded biotech infrastructure projects incorporate single-use platforms.

Asia-Pacific

Asia-Pacific represents 24% share, with China and India contributing 60% of regional installations. Over 35% increase in biologics facilities occurred between 2021 and 2024. Approximately 48% of new facilities adopt single-use systems. South Korea operates over 25 large biologics plants, with 50% utilizing disposable upstream technologies.

Middle East & Africa

Middle East & Africa hold 5% share, with over 40 emerging biotech hubs. Approximately 30% of new facilities in the UAE and Saudi Arabia integrate single-use platforms. Around 25% of vaccine production facilities in Africa utilize disposable filtration units. Nearly 18% increase in regional biotech investments occurred between 2022 and 2024.

List of Top Single-use Bioprocessing Material Companies

• Thermo Fisher Scientific (US)
• Sartorius Stedim Biotech S.A (France)
•  

These 2 companies collectively hold approximately 38% of global Single-use Bioprocessing Material Market Share, with Thermo Fisher accounting for around 22% and Sartorius holding nearly 16%. Both operate in over 30 countries and maintain more than 15 manufacturing sites each dedicated to disposable systems.

Investment Analysis and Opportunities

Over 48% of biologics manufacturers increased capital allocation toward single-use capacity expansion between 2022 and 2024. Approximately 35% of new greenfield facilities utilize modular single-use configurations. Venture investments in cell and gene therapy infrastructure increased by 28% during 2023. Nearly 60% of CDMOs expanded disposable assembly production lines. Asia-Pacific attracted 32% of new facility investments globally. The Single-use Bioprocessing Material Market Opportunities include 45% reduction in facility build timelines and 30% improvement in operational flexibility. Government-backed biotech initiatives in over 15 countries support disposable manufacturing infrastructure.

New Product Development

Between 2023 and 2025, over 35% of new product launches focused on automation-compatible disposable sensors. Approximately 40% of sterile connector innovations enhanced leak-proof assurance by 25%. Nearly 30% of new bioreactor bag models improved oxygen transfer rates by 18%. Around 22% of manufacturers introduced recyclable polymer blends. Over 50% of next-generation filtration capsules extended throughput capacity by 15%. The Single-use Bioprocessing Material Market Trends emphasize integration of digital monitoring modules in 45% of new system releases.

Five Recent Developments (2023–2025)

1. In 2023, a leading manufacturer expanded single-use production capacity by 30% across 2 facilities.
2. In 2024, a global supplier launched 15 new disposable sensor models with 20% enhanced accuracy.
3. In 2024, a company invested in a 40,000-square-foot facility dedicated to filtration assemblies.
4. In 2025, a manufacturer introduced recyclable bag systems reducing polymer waste by 18%.
5. Between 2023 and 2025, 3 major players expanded Asia-Pacific operations by 25%.

Report Coverage of Single-use Bioprocessing Material Market

The Single-use Bioprocessing Material Market Report covers over 20 countries, analyzing more than 50 manufacturers and 4 primary material types. The report evaluates 10-year installation data across 500+ facilities globally. It includes segmentation by 3 material categories and 4 application sectors, representing 100% of market demand distribution. Regional analysis spans North America (38%), Europe (30%), Asia-Pacific (24%), and Middle East & Africa (5%). The Single-use Bioprocessing Material Market Research Report provides insights into 25 regulatory frameworks and assesses over 40 recent product innovations between 2023 and 2025.